118 related articles for article (PubMed ID: 10650152)
1. Mechanism of inhibition of platelet aggregation by HCL-31D.
Chou TC; Li CY; Lee AR; Wu TM
Eur J Pharmacol; 2000 Jan; 387(2):125-31. PubMed ID: 10650152
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the antiplatelet effect of C-phycocyanin.
Chiu HF; Yang SP; Kuo YL; Lai YS; Chou TC
Br J Nutr; 2006 Feb; 95(2):435-40. PubMed ID: 16469164
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Liao CH; Ko FN; Wu CL; Teng CM
J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effect of demethyldiisoeugenol.
Liao CH; Ko FN; Kuo YH; Teng CM
Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory mechanisms of dantrolene on platelet aggregation.
Chou TC; Li CY
Thromb Res; 1999 Nov; 96(4):299-307. PubMed ID: 10593433
[TBL] [Abstract][Full Text] [Related]
9. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma.
Ko FN; Lee YS; Kuo SC; Chang YS; Teng CM
Biochim Biophys Acta; 1995 Sep; 1268(3):329-34. PubMed ID: 7548232
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
Sheu JR; Hung WC; Lee YM; Yen MH
Eur J Pharmacol; 1996 Dec; 318(2-3):469-75. PubMed ID: 9016940
[TBL] [Abstract][Full Text] [Related]
11. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
[TBL] [Abstract][Full Text] [Related]
12. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
Liao CH; Ko FN; Kuo SC; Teng CM
Jpn J Pharmacol; 1998 Feb; 76(2):141-8. PubMed ID: 9541276
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Ding YA; Chou TC; Chern JW; Yen MH
Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
[TBL] [Abstract][Full Text] [Related]
14. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.
Sheu JR; Lee CR; Lin CC; Kan YC; Lin CH; Hung WC; Lee YM; Yen MH
Br J Pharmacol; 1999 Jul; 127(5):1206-12. PubMed ID: 10455267
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effect of gingerol isolated from Zingiber officinale.
Guh JH; Ko FN; Jong TT; Teng CM
J Pharm Pharmacol; 1995 Apr; 47(4):329-32. PubMed ID: 7791032
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
Lin CH; Kuo YH; Lin YL; Teng CM
J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
Chou TC; Hsu LY; Yen MH; Ding YA
Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
